Ranulf Orr
Stock Analyst at Citi
(1.19)
# 3,474
Out of 4,334 analysts
88
Total ratings
46.5%
Success rate
-1.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ranulf Orr
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0Q4U Novozymes A/S | Maintained: Buy | $415 → $440 | $387.70 | +13.49% | 5 | May 8, 2026 | |
| SWX: GIVN Givaudan SA | Maintained: Hold | $3,350 → $3,150 | $2,882.00 | +9.30% | 18 | Mar 17, 2026 | |
| LON: TATE Tate & Lyle plc | Maintained: Buy | $5 | $508.50 | -99.02% | 1 | Feb 27, 2026 | |
| EPA: AKE Arkema S.A. | Maintained: Buy | $80 → $70 | $59.20 | +18.24% | 9 | Dec 12, 2025 | |
| LON: 0NZR Solvay SA | Maintained: Hold | $27 → $26 | $26.10 | -0.38% | 4 | Dec 12, 2025 | |
| SWX: CLN Clariant AG | Downgraded: Hold | $12 → $7.8 | $7.94 | -1.70% | 11 | Dec 11, 2025 | |
| LON: VCT Victrex plc | Maintained: Hold | $700 | $633.00 | +10.58% | 1 | Dec 9, 2025 | |
| LON: JMAT Johnson Matthey Plc | Maintained: Hold | $21 | $2,190.00 | -99.04% | 6 | Dec 1, 2025 | |
| LON: CRDA Croda International Plc | Maintained: Hold | $33 → $31 | $2,991.00 | -98.98% | 6 | Oct 3, 2025 | |
| LON: 0RUY Umicore SA | Maintained: Hold | $14 | $26.12 | -46.40% | 8 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $75 | $53.44 | n/a | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 | $79.70 | n/a | 4 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $44 | $51.35 | n/a | 2 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $430 | $527.73 | n/a | 1 | Jan 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $111 → $108 | $100.70 | n/a | 2 | Nov 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $58 | $59.80 | n/a | 2 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 | $16.84 | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $165 | $184.16 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $75.28 | n/a | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $60.11 | n/a | 2 | Aug 15, 2019 |
Novozymes A/S
May 8, 2026
Maintained: Buy
Price Target: $415 → $440
Current: $387.70
Upside: +13.49%
Givaudan SA
Mar 17, 2026
Maintained: Hold
Price Target: $3,350 → $3,150
Current: $2,882.00
Upside: +9.30%
Tate & Lyle plc
Feb 27, 2026
Maintained: Buy
Price Target: $5
Current: $508.50
Upside: -99.02%
Arkema S.A.
Dec 12, 2025
Maintained: Buy
Price Target: $80 → $70
Current: $59.20
Upside: +18.24%
Solvay SA
Dec 12, 2025
Maintained: Hold
Price Target: $27 → $26
Current: $26.10
Upside: -0.38%
Clariant AG
Dec 11, 2025
Downgraded: Hold
Price Target: $12 → $7.8
Current: $7.94
Upside: -1.70%
Victrex plc
Dec 9, 2025
Maintained: Hold
Price Target: $700
Current: $633.00
Upside: +10.58%
Johnson Matthey Plc
Dec 1, 2025
Maintained: Hold
Price Target: $21
Current: $2,190.00
Upside: -99.04%
Croda International Plc
Oct 3, 2025
Maintained: Hold
Price Target: $33 → $31
Current: $2,991.00
Upside: -98.98%
Umicore SA
Aug 7, 2025
Maintained: Hold
Price Target: $14
Current: $26.12
Upside: -46.40%
Apr 29, 2025
Maintained: Buy
Price Target: $84 → $75
Current: $53.44
Upside: n/a
Apr 25, 2025
Maintained: Buy
Price Target: $120
Current: $79.70
Upside: n/a
Sep 27, 2024
Maintained: Hold
Price Target: $45 → $44
Current: $51.35
Upside: n/a
Jan 18, 2024
Maintained: Buy
Price Target: $430
Current: $527.73
Upside: n/a
Nov 6, 2023
Maintained: Sell
Price Target: $111 → $108
Current: $100.70
Upside: n/a
Oct 17, 2023
Maintained: Buy
Price Target: $54 → $58
Current: $59.80
Upside: n/a
Oct 11, 2023
Maintained: Hold
Price Target: $24
Current: $16.84
Upside: n/a
Aug 18, 2023
Maintained: Buy
Price Target: $165
Current: $184.16
Upside: n/a
Jul 20, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $75.28
Upside: n/a
Aug 15, 2019
Reiterated: Hold
Price Target: n/a
Current: $60.11
Upside: n/a